Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Smith

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Alzheimer'S Research & Therapy|September 16, 2024
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer's diseaseAnika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYu Xiao, Nicola Spotorno, Lijun An, et al.
Human Molecular Genetics|November 5, 2004
Orexin loss in Huntington's diseaseAsa Petersén, Joana Gil, Marion L C Maat-Schieman, et al.
Brain : a Journal of Neurology|October 29, 2025
Biological classification of memory clinic patientsSophie E Mastenbroek, Lyduine E Collij, Toomas Erik Anijärv, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 3, 2023
Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's diseaseTharick A Pascoal, Antoine Leuzy, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersToomas Erik Anijärv, Ruben Smith, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumToomas Erik Anijärv, Ruben Smith, Lyduine E Collij, et al.
Nature Communications|April 5, 2020
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's diseaseShorena Janelidze, Erik Stomrud, Ruben Smith, et al.
Brain : a Journal of Neurology|March 26, 2023
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysisDiana I Bocancea, Anna L Svenningsson, Anna C van Loenhoud, et al.
BMJ Open|December 30, 2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's diseaseGesine Paul, Hjalmar Bjartmarz, Anders Björklund, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Alzheimer'S Research & Therapy|September 16, 2024
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer's diseaseAnika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYu Xiao, Nicola Spotorno, Lijun An, et al.
Human Molecular Genetics|November 5, 2004
Orexin loss in Huntington's diseaseAsa Petersén, Joana Gil, Marion L C Maat-Schieman, et al.
Brain : a Journal of Neurology|October 29, 2025
Biological classification of memory clinic patientsSophie E Mastenbroek, Lyduine E Collij, Toomas Erik Anijärv, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 3, 2023
Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's diseaseTharick A Pascoal, Antoine Leuzy, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersToomas Erik Anijärv, Ruben Smith, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumToomas Erik Anijärv, Ruben Smith, Lyduine E Collij, et al.
Nature Communications|April 5, 2020
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's diseaseShorena Janelidze, Erik Stomrud, Ruben Smith, et al.
Brain : a Journal of Neurology|March 26, 2023
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysisDiana I Bocancea, Anna L Svenningsson, Anna C van Loenhoud, et al.
BMJ Open|December 30, 2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's diseaseGesine Paul, Hjalmar Bjartmarz, Anders Björklund, et al.
Pageof 14